IODINE is an essential trace element for synthesis of thyroid hormones and thyroxine (T4) is also essential for brain development. Iodine deficiency (ID) might cause hypothyroidism resulting in severe developmental delay in infants and stillbirth in pregnant women [1, 2] . Patients on long-term total enteral nutrition (TEN) are at risk of ID because of the low iodine content of EN formulae (Table 1) [3] [4] [5] . We measured urinary iodine concentration (UIC) in patients with severe motor and intellectual disabilities (SMID) receiving long-term TEN. We also provided iodine supplementation (IS) for ID cases in the form of powdered kelp and monitored their thyroid function, UIC, biochemical parameters and vital signs.
years, average 21.4 ± 18.4 years) patients living in an Otaru city nursing home from June 2009 to May 2010 in this study. All of the patients had been receiving TEN at this nursing home for over one year because of their swallowing disorder. Labels of EN formulae used were: Ensure ® (Abbott) in 10, Racol ® (Ostuka) in 8, E-3 ® (Clinico) in 11, and other preparations in 6 cases. Their average daily iodine intake was calculated to be 19.8 ± 15.1 μg. Excepting two cases, all patients were on medication for epilepsy including carbamazepine and phenytoin which could suppress thyroid function [6] . There was no specific choice of antiepileptics. Two were formally diagnosed as being hypothyroid.
Methods

Chart of the investigation
We divided our investigation into three stages (Fig. 1 );
Stage 1 (Investigation of baseline UIC and thyroid function)
We measured UIC, thyroid function (TSH, free triiodothyronine (FT3), freeT4 (FT4)), and anti-thyroidantibodies (Anti-thyroglobulin-antibody (ATA), anti-
Definition of HID
The diagnosis of HID depended on the WHO criteria of ID (UIC < 100 μg/L), and hypothyroidism (TSH > 4.0 μIU/mL or FT4 < 0.8 ng/dL) without elevation of ATA and APA (Table 2) [1, 2] . Low UIC and hypothyroidism which remitted after IS were also considered as HID.
Method of IS
When participants had a UIC < 100 μg/L, we provided them with 1-2 g/day (200-400 μg/day iodine) of powdered kelp dissolved in EN formula or in a small amount of water and fed through their nutritional tubes. During IS, we did not alter their daily calorie intake, labels of their nutrition, or their medications for epilepsy. thyroid peroxidase-antibody (APA)) in all subjects.
Stage 2 (Short-term IS)
Twenty-eight subjects whose UIC was less than 100 μg/L in Stage 1 and who agreed to short-term IS participated. Vital signs (body temperature (°C), blood pressure (mmHg), heart rate (per minute)) were recorded. We compared the average data for three days before and after IS. We also measured thyroid function, creatinine phosphokinase (CPK) (IU/L), and total cholesterol (Tcho) (mg/dL) before and after IS. UIC after IS was also measured.
Stage 3 (long-term IS)
Twenty-two subjects who joined Stage 2 and who agreed to long-term IS participated and we measured their thyroid function after five-month supplementation and compared it before and after IS values. 
Results
Stage 1
Thirty-four (97.1 %) of the thirty-five subjects on long-term TEN had a UIC less than 100 μg/L. UIC in twenty-two (62.8%) was below the lower limit level (< 25 μg/L) ( Fig. 2 ). Six (17.1%) were hypothyroid ( Table 3 ) and two of them had clinical manifestations of hypothyroidism such as prolonged sleeping time (about
Laboratory analysis
Early morning spot urine samples were obtained, and rapidly frozen at -20 °C until they were analyzed. UIC was measured by the Sandell-Kolthoff reaction using 96-well micro plates (HITACHI) [7] .
Statistical analysis
We compared thyroid function, biochemical data, average vital data of three days before and after iodine supplementation, using Students t-test for Stage 2 and 3 data. We also compared UIC using McNemar's analysis in Stage 2. Significance was set at p <0.05 in both analyses.
Informed consent
Before the investigation, informed consent for all biochemical testing including thyroid function and UIC measurement was obtained from family members or guardians of all patients according to Helsinki declaration. We provided the results if requested by the family. Fig. 2 The UIC level of all subjects More than 90% showed ID and over 60% of them had ID, out of the lower limit level.
twelve hours) in case 4, and morning hypothermia (34.7 °C) in case 5. ATA and APA were negative in all thirtyfive subjects. None of the patients had a goiter.
Stage 2
Twenty-eight subjects reached Stage 2. There was no significant difference in the means of most parameters before and after short-term IS (Table 4 ). However, UIC after IS rose significantly (p < 0.001) ( Fig. 3) . Improvement of TSH level was confirmed in five (14.7%) of six hypothyroidism cases (Fig.4) . They were finally diagnosed as HID. One patient showed no change in his TSH and hypothyroidism persisted (case 6). His hypothyroidism was considered to result from medication for epilepsy or pituitary TSH secreting disorder. The limit is set at 50 µg/L, that is a lower-criterion as Moderate ID [1] . One dot represents one participant. UIC less than 50 µg/L, elevated more than the limit after onemonth IS, black dots( ); elevated UIC but in the range of 25-50 μg/L, meshed dots( ); UIC was more than 50 µg/L before IS and elevated more after IS, white dots ( ). The results of McNemar's analysis gave a p < 0.001.
urging some company to add iodine to its formulae. On the other hand, five subjects (14.7%) among them were diagnosed as having HID. The incidence of HID is surprisingly low in view of the extremely low iodine intake but may actually be in line with other data from population studies [9] [10] [11] [12] [13] [14] or may reflect difficulty in recognizing hypothyroid state in these patients or may be due to thyroid adaptive processes [15] [16] [17] [18] . Possibly SMID patients, the targets of this study, might be at risk of developing disorders with a poor response of TSH that renders their hypothyroidism difficult to diagnose. In fact the majority of them have hypothalamus-pituitary disorders resulting from hypoxic episodes in their early childhood. Furthermore, in 5 subjects with HID except case 4, the TSH response may be insufficient to correspond to their lower FT4.
A thyroid adaptation mechanism exists in some subjects with iodine deficiency. Some experimental reports document that early thyroid adaptation develops after short-term (about one month) iodine deficiency, e.g. angiogenesis in the thyroid gland to increase iodine absorption without TSH stimulation, or tissue-selective acceleration of deiodinase activity resulting in T4 to T3 conversion [15] [16] [17] [18] . Therefore, modest increase TSH, high normal or increased T3, and low normal or decreased T4 might be detected in iodine deficient state [19] . In the present study, there was a significant decrease of FT3 after five-month IS. This could represent elevation of FT3 before IS, suggesting the existence of an adaptive mechanism such as deiodinase activation. However, the correlation of T3 and ID varied in different reports [13, 14, 20] . It remains to be elucidated whether same thyroid adaptation occurs
Stage 3
In this group, consisting of twenty-two subjects, a significant reduction of FT3 were detected (p < 0.05), however, changes of TSH and FT4 were not significant ( Fig. 5 ). TSH in five HID cases improved after one month IS and remained at normal throughout fivemonth IS (Fig. 4) . Clinical manifestations in cases 4 and 5 remitted.
Discussion
Worldwide, approximately 30% of the population, which is about 1,900 million people, has an inadequate iodine intake. The diagnosis of ID depended on UIC [1, 2] . This is the first survey of iodine status involving an "at risk" SMID population receiving long-term TEN who were living a nursing home in Japan. A few case reports on ID in subjects on long-term TEN have been published since the early 1990's [4, 5] , however, there has been no systematic investigation of iodine status in large SMID populations receiving long-term TEN. Iodine status in such patients depends entirely on the iodine content of the EN formulae. When they take 1,500 Cal of the EN solutions available in our country, their daily iodine intakes are far below the level of the Ministry of Health, Labor and Welfare recommendation, which is 35-140 μg for children and adolescents, and 95-270 μg for adults [5, 8] .
In the present study, with one exception, all participants were iodine deficient. This highlights the fact that ID is a common major adverse effect of long-term TEN in our country. Recently, the Japanese Society for Pediatric Endocrinology issued a special statement cific clinical symptoms including goiter. Symptoms which improved after IS were found in only two cases. Hypothyroidism in SMID might have been difficult to detect and we should increase our awareness of possible HID in SMID.
Conclusion
We investigated the iodine status of SMID on longterm TEN. Most had ID. Simple powdered kelp supplementation was effective for SMID. Only five were diagnosed as HID. Adaptive mechanisms in thyroid function in the iodine deficient state might act to maintain their thyroid hormone synthesis. even in the chronic and severe ID which develops in SMID on long-term TEN.
Several investigators concluded that significant remission of thyroid function was brought about after IS, especially in iodine status [11] [12] [13] [14] 20] . In our study, however, statistically significant alteration of thyroid function was not detected even after the entire period of long-term IS, although short-term IS caused clear remission of thyroid dysfunction and significant UIC elevation in 5 HID cases. IS also effectively resolved some of the clinical symptom of hypothyroidism, e.g. oversleeping and low body temperature. Daily powdered kelp supplementation might be one of the most effective and easiest methods to treat ID in SMID on TEN.
SMID in our investigation seldom had any spe-
